Rapid Micro Biosystems (RPID) Set to Announce Earnings on Tuesday

Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, May 10th. Analysts expect Rapid Micro Biosystems to post earnings of ($0.33) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) last released its quarterly earnings results on Friday, March 4th. The company reported ($0.35) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.35). The firm had revenue of $5.21 million for the quarter, compared to analyst estimates of $4.86 million. Rapid Micro Biosystems had a negative net margin of 316.48% and a negative return on equity of 177.70%. On average, analysts expect Rapid Micro Biosystems to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

NASDAQ:RPID opened at $5.60 on Tuesday. Rapid Micro Biosystems has a 12 month low of $4.81 and a 12 month high of $27.04. The company’s 50-day moving average price is $6.46 and its two-hundred day moving average price is $10.12.

In other news, Director Inese Lowenstein acquired 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 10th. The stock was purchased at an average price of $6.95 per share, for a total transaction of $69,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 38.04% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of RPID. California State Teachers Retirement System acquired a new stake in Rapid Micro Biosystems in the 3rd quarter valued at approximately $80,000. Citadel Advisors LLC acquired a new stake in Rapid Micro Biosystems in the 3rd quarter valued at approximately $419,000. Millennium Management LLC acquired a new stake in Rapid Micro Biosystems in the 3rd quarter valued at approximately $400,000. Bank of New York Mellon Corp acquired a new stake in Rapid Micro Biosystems in the 3rd quarter valued at approximately $289,000. Finally, American International Group Inc. acquired a new stake in Rapid Micro Biosystems in the 3rd quarter valued at approximately $81,000. 69.77% of the stock is owned by institutional investors and hedge funds.

Several research analysts have issued reports on RPID shares. Morgan Stanley reduced their price objective on Rapid Micro Biosystems from $11.00 to $10.00 and set an “equal weight” rating on the stock in a report on Monday, March 7th. Zacks Investment Research raised Rapid Micro Biosystems from a “hold” rating to a “buy” rating and set a $7.00 price objective on the stock in a report on Saturday, March 12th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $18.75.

About Rapid Micro Biosystems (Get Rating)

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services.

See Also